SMi are proud to present their 4th annual European Conference on KOL Management & MSL Best Practice in Europe, to be held on 2nd & 3rd July 2012 in Basel, Switzerland. The 2012 event will bring together senior Pharma executives and key opinion leaders to discuss current issues in the field. With presentations from industry representatives from all over the pharmaceutical sector, this event promises to be a unique platform for networking and problem solving.

Key Benefits of Attending:

• Hear from leading industry experts from major pharmaceutical companies about compliance challenges in KOL interaction
• Consider effective MSL development strategies in orphan disease markets
• Understand the importance of KOL management in developing countries
• Discuss with patient advocacy groups how best to build and sustain industry-academia relationships
• Explore MSL best practice strategies in promotional and marketing activities
• Learn how best to utilize digital media in KOL management
  

HEAR KEY PRESENTATIONS FROM EXPERTS IN THE FIELD:

• Key factors in KOL management - Soren Skovlund, Global Director, Novo Nordisk
• MSL in Orphan Disease: Hand-in-hand with a targeted sales force - Andreas Brecht, Medical Science Liaison, Actelion
• New developments and relationships in continuing medical education (CME) - Tom Pulles, International Medical Director, Shire
• KOL management in developing countries, - Stephen Toovey, Medical Consultant, Virology, Roche Pharmaceuticals
• Joint Presentation: Ensuring a successful relationship between Industry & Patients, - Keith Allan, Head of Global Product Advocacy, Novartis, Susanna Palkonen, Chairman, European Federation of Allergy and Airways Diseases Patients Associations
  

Quote “Lab Bulletin” & save £100!

For further information click here